U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H28O2
Molecular Weight 276.4137
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 19-NORANDROSTERONE

SMILES

C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@H]34)[C@@H]1CCC2=O

InChI

InChIKey=UOUIARGWRPHDBX-CQZDKXCPSA-N
InChI=1S/C18H28O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h11-16,19H,2-10H2,1H3/t11-,12+,13-,14+,15+,16-,18-/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H28O2
Molecular Weight 276.4137
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Determination of nandrolone metabolites in human urine: comparison between liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry.
2010-07-15
Influence of delivery mode on the urinary excretion of nandrolone metabolites.
2010-04
Nandrolone excretion in sedentary vs physically trained young women.
2010-02
[Possible reasons for the presence of nandrolone metabolites in urine].
2010-01-16
Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control.
2010-01-01
Steroid metabolism in chimeric mice with humanized liver.
2009-11
Analysis of conjugated steroid androgens: deconjugation, derivatisation and associated issues.
2009-07-12
Urinary nandrolone metabolite detection after ingestion of a nandrolone precursor.
2009-04
Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone.
2009-03
Profiling of 19-norandrosterone sulfate and glucuronide in human urine: implications in athlete's drug testing.
2009-03
Excretion of norsteroids' phase II metabolites of different origin in human.
2009-03
Doping in sport--1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone.
2009-03
Quantitative analysis of DHEA and androsterone in female urine: investigating the effects of menstrual cycle, oral contraception and training on exercise-induced changes in young women.
2009-02
Urinary metabolic profile of 19-norsteroids in humans: glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol.
2008-10
Elimination kinetic of 17beta-estradiol 3-benzoate and 17beta-nandrolone laureate ester metabolites in calves' urine.
2008-05
Direct detection and quantification of 19-norandrosterone sulfate in human urine by liquid chromatography-linear ion trap mass spectrometry.
2007-06-01
Concentrations of nandrolone metabolites in urine after the therapeutic administration of an ophthalmic solution.
2007-05-09
Synthesis and analytics of 2,2,3,4,4-d5-19-nor-5alpha-androsterone--an internal standard in doping analysis.
2007-05
Analysis of a challenging subset of World Anti-Doping Agency-banned steroids and antiestrogens by LC-MS-MS.
2007-04
Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
2007-04
Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry.
2006-09
Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids.
2006-09
Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry.
2006-08
Significance of 19-norandrosterone in athletes' urine samples.
2006-07
Development and evaluation of a candidate reference measurement procedure for the determination of 19-norandrosterone in human urine using isotope-dilution liquid chromatography/tandem mass spectrometry.
2006-05-15
Research of stimulants and anabolic steroids in dietary supplements.
2006-02
Contamination of dietary supplements and positive drug tests in sport.
2005-09
Unintentional doping through the use of contaminated nutritional supplements.
2005-07
Formation of 19-norsteroids by in situ demethylation of endogenous steroids in stored urine samples.
2005-07
Effects of high-intensity exercises on 13C-nandrolone excretion in trained athletes.
2005-05
Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men.
2005-05
Quantification and profiling of 19-norandrosterone and 19-noretiocholanolone in human urine after consumption of a nutritional supplement and norsteroids.
2005-03
Norandrosterone and noretiocholanolone concentration before and after submaximal standardized exercise.
2004-10
[13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism.
2004-02
Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.
2003-09
Testing for nandrolone metabolites in urine samples of professional athletes and sedentary subjects by GC/MS/MS analysis.
2002-12
Nandrolone excretion is not increased by exhaustive exercise in trained athletes.
2002-09
Endogenous nandrolone metabolites in human urine. Two-year monitoring of male professional soccer players.
2002-03-13
Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin.
2002-02
Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control.
2002-01-25
Urinary 19-norandrosterone purification by immunoaffinity chromatography: application to gas chromatography/combustion/isotope ratio mass spectrometric analysis.
2002
Detection of nandrolone metabolites in urine after a football game in professional and amateur players: a Bayesian comparison.
2001-11-01
Endogenous origin of norandrosterone in female urine: indirect evidence for the production of 19-norsteroids as by-products in the conversion from androgen to estrogen.
2001-10
Determination of nandrolone and metabolites in urine samples from sedentary persons and sportsmen.
2001-09-25
Gas chromatography-combustion-isotope ratio mass spectrometry analysis of 19-norsteroids: application to the detection of a nandrolone metabolite in urine.
2001-08-15
Urinary nandrolone metabolites of endogenous origin in man: a confirmation by output regulation under human chorionic gonadotropin stimulation.
2001-01
Consequence of boar edible tissue consumption on urinary profiles of nandrolone metabolites. II. Identification and quantification of 19-norsteroids responsible for 19-norandrosterone and 19-noretiocholanolone excretion in human urine.
2001
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:43:25 GMT 2025
Edited
by admin
on Mon Mar 31 23:43:25 GMT 2025
Record UNII
5W4XKU708V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
J109.668K
Preferred Name English
19-NORANDROSTERONE
Common Name English
5.ALPHA.-ESTRAN-3.ALPHA.-OL-17-ONE
Systematic Name English
5.ALPHA.-ESTRAN-17-ONE, 3.ALPHA.-HYDROXY-
Systematic Name English
ESTRAN-17-ONE, 3-HYDROXY-, (3.ALPHA.,5.ALPHA.)-
Systematic Name English
Code System Code Type Description
CAS
1225-01-0
Created by admin on Mon Mar 31 23:43:25 GMT 2025 , Edited by admin on Mon Mar 31 23:43:25 GMT 2025
PRIMARY
FDA UNII
5W4XKU708V
Created by admin on Mon Mar 31 23:43:25 GMT 2025 , Edited by admin on Mon Mar 31 23:43:25 GMT 2025
PRIMARY
EPA CompTox
DTXSID10893662
Created by admin on Mon Mar 31 23:43:25 GMT 2025 , Edited by admin on Mon Mar 31 23:43:25 GMT 2025
PRIMARY
PUBCHEM
9548753
Created by admin on Mon Mar 31 23:43:25 GMT 2025 , Edited by admin on Mon Mar 31 23:43:25 GMT 2025
PRIMARY
WIKIPEDIA
19-Norandrosterone
Created by admin on Mon Mar 31 23:43:25 GMT 2025 , Edited by admin on Mon Mar 31 23:43:25 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
MAJOR
PARENT -> METABOLITE